1 Semicarbazide-sensitive amine oxidase (SSAO) activity has been demonstrated in the isolated mesenteric arterial bed of the rat in vitro by studying the metabolism of benzylamine (Bz) and tyramine (Tyr) added to the perfusing fluid. 2 Pretreatment of rats with (E)-2-(3',4'-dimethoxyphenyl)-3-fluoroallylamine (MDL72145), a potent inhibitor of SSAO in rat mesenteric blood vessels, reduced the amount of metabolites, following the addition of Bz (25 uM) or Tyr (100pM) to the perfusing fluid, by 83% and 52% respec-' tively. Inactivation of monoamine oxidase type A (MAO-A) by the addition of clorgyline (10pM) to the perfusing fluid, had little effect on the appearance of metabolites from Tyr. 3 The presence of 3 UM cocaine in the perfusing fluid increased the amount of metabolites produced from Tyr. 4 The metabolites of Tyr appearing in the perfusion fluid from control preparations were 85% p-hydroxyphenylacetic acid and the remainder consisted of a mixture of phydroxyphenylacetaldehyde and, possibly, p-hydroxyphenylethanol. 5 The metabolism of Tyr by homogenates of the rat mesenteric vascular bed was carried out by SSAO (60%) and MAO-A (40%) with very little contribution from MAO-B. Homogenates from rats pretreated with MDL 72145 showed metabolism of Tyr by MAO-A only. 6 These data indicate that SSAO is capable of metabolizing amines present in the fluid perfusing blood vessels to metabolites that are readily released. Histochemical evidence has shown that whereas MAO-A is present in the mitochondria of smooth muscle cells and nerve endings, SSAO is located in the plasma membrane of the smooth muscle cells. This subcellular distribution may explain the differences found between metabolites released from intact vessels and the metabolism seen in homogenates. The identity of the Tyr metabolizing activity in intact vessels that is resistant to both MDL 72145 and clorgyline remains to be determined.
IntroductionRat blood vessels possess an amine oxidase activity capable of metabolising tyramine (Tyr), which has different properties from monoamine oxidase (MAO; EC 1.4.3.4) enzymes (Coquil et al., 1973 Callingham & Barrand 1987, for review). SSAO has been shown to reside in the plasma membrane of vascular smooth muscle cells (Wibo et al., 1980;Lyles & Singh, 1985).Homogenates of blood vessels have been widely used to examine the biochemical properties of this enzyme activity (Lewinsohn et al., 1978;Clarke et al., 1982;Precious et al., 1988;Elliott et al., 1989b).The preferred substrate appears to be benzylamine (Bz) but a number of aromatic and aliphatic amines also have been shown to be substrates. In spite of all the work done with homogenates, this enzyme has not been studied in intact blood vessels of the rat and its physiological significance is poorly understood.Studies with intact rat caudal artery confirm the long held view that neuronal uptake mechanisms are important for the inactivation of noradrenaline. Catechol-O-methyltransferase and extraneuronal uptake make a more significant contribution when the ...